TR201111221T2 - Pharmaceutical combinations of simethicone and otilonium. - Google Patents

Pharmaceutical combinations of simethicone and otilonium.

Info

Publication number
TR201111221T2
TR201111221T2 TR2011/11221T TR201111221T TR201111221T2 TR 201111221 T2 TR201111221 T2 TR 201111221T2 TR 2011/11221 T TR2011/11221 T TR 2011/11221T TR 201111221 T TR201111221 T TR 201111221T TR 201111221 T2 TR201111221 T2 TR 201111221T2
Authority
TR
Turkey
Prior art keywords
simethicone
pharmaceutical combinations
otilonium
kits
pain
Prior art date
Application number
TR2011/11221T
Other languages
Turkish (tr)
Inventor
Vedat E��Lmez Mehmet
Original Assignee
Abd� �Brah�M �La� Sanay� Ve T�Caret Anon�M ��Rket�@
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abd� �Brah�M �La� Sanay� Ve T�Caret Anon�M ��Rket�@ filed Critical Abd� �Brah�M �La� Sanay� Ve T�Caret Anon�M ��Rket�@
Publication of TR201111221T2 publication Critical patent/TR201111221T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Buluş; simetikon ve otilonjyum bromürün farmasötik kombinasyonları, bileşimleri ve kitlerinin yanı sıra; irritabıl bağırsak sendromu (IBS), distal enterik bölgede ağrı ve spazm ile gastrointestinal bölgede çok fazla gaz ağrısı semptomlarına sahip hastaları tedavi etmek için söz konusu kombinasyon, bileşim ve kitlerin kullanımı hakkındadır.Meet; as well as pharmaceutical combinations, compositions and kits of simethicone and otilongium bromide; It relates to the use of said combination, composition and kits to treat patients with irritable bowel syndrome (IBS), pain and spasm in the distal enteric region, and symptoms of excessive gas pain in the gastrointestinal region.

TR2011/11221T 2009-02-12 2009-02-12 Pharmaceutical combinations of simethicone and otilonium. TR201111221T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2009/050568 WO2010092436A1 (en) 2009-02-12 2009-02-12 Pharmaceutical combinations of simethicone and otilonium

Publications (1)

Publication Number Publication Date
TR201111221T2 true TR201111221T2 (en) 2012-02-21

Family

ID=41259864

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2011/11221T TR201111221T2 (en) 2009-02-12 2009-02-12 Pharmaceutical combinations of simethicone and otilonium.

Country Status (2)

Country Link
TR (1) TR201111221T2 (en)
WO (1) WO2010092436A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201270309A1 (en) * 2009-08-24 2012-07-30 Абды Ибрахым Иладж Санайи Ве Тыджарет Аноным Сыркеты OTILONIA TABLETS RECEIVED BY DIRECT PRESSING
EP2481395A1 (en) * 2011-02-01 2012-08-01 Deva Holding Anonim Sirketi Sachet, effervescent tablet and dry syrup of otilonium
CN104523717A (en) * 2015-01-06 2015-04-22 西南大学 Simethicone otilonium bromide chewable tablets and preparing method thereof
MA41620A (en) * 2015-05-14 2018-01-09 Abdi Ibrahim Ilac Sanayi Ve Ticaret A S PHARMACEUTICAL COMPOSITION CONSISTING OF SIMETHICONE AND OTILONIUM
US20180311201A1 (en) * 2015-06-12 2018-11-01 Santa Farma ?Laç Sanay? A. ?. Oral pharmaceutical composition comprising otilonium bromide and simethicone with certain bulk density and improved dissolution characteristics

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1216283B (en) * 1986-11-04 1990-02-22 Menarini Sas USE OF OCTILONIUM BROMIDE (DCI) FOR TOPICAL APPLICATION IN THE GASTRO-INTESTINAL TRACT AND RELATED PHARMACEUTICAL FORMULATION APPROPRIATE FOR SUCH USE.

Also Published As

Publication number Publication date
WO2010092436A1 (en) 2010-08-19

Similar Documents

Publication Publication Date Title
EA201300323A1 (en) MATERIALS AND METHODS OF IMPROVEMENT OF THE FUNCTION OF THE GASTROINTESTINAL TRACT
EA200870185A1 (en) COMBINATION OF ANG2 AND VEGF INHIBITORS
CL2008003694A1 (en) Compounds derived from substituted heterocycle-2-carboxamide; pharmaceutical composition; pharmaceutical combination; and its use as inhibitors of dipeptidyl peptidase iv (dpp-iv) in the treatment of asthma, copd and allergic rhinitis.
CL2011002787A1 (en) Substituted 1-cyanoethylheterocyclylcarboxamide derivative compounds, dipeptidylpeptidase i (dppi) or cathepsin c inhibitors; pharmaceutical composition; pharmaceutical combination; and its use in the treatment of asthma, chronic obstructive disease or allergic rhinitis.
EA201200977A1 (en) TREATMENT OF SYNDROME OF LEE AND LIKE-LIKE SYNDROME
CL2011002857A1 (en) Compounds derived from phenyl or heteroaryl pyridine, aldosterone synthase inhibitors; pharmaceutical composition comprising a compound; pharmaceutical combination comprising a compound; and use of the compounds in the treatment of cardiovascular diseases.
NO20092637L (en) Methods of treatment
EA201270619A1 (en) USE OF BETANEHOL FOR THE TREATMENT OF XEROSTOMY
BRPI0917017B8 (en) s-nitrosoglutathione reductase pyrrole inhibitors as therapeutic agents
BR112012029395A2 (en) piperdinyl-substituted lactams as gpr119 modulators
UY32728A (en) PHARMACEUTICAL COMPOSITION AND TREATMENT PROCEDURE FOR EMERGENCY ANTI-CONCEPT
EA201491358A1 (en) INTRODUCED ORAL CORRECTIC STERILE COMPOSITIONS
EA201290183A1 (en) BENZODIAZEPINUM INHIBITOR BROMODOMENE
EA201071320A1 (en) АКТИВАТОРЫ ГЛЮКОКИНАЗЫ
EA201491009A1 (en) PLATINOUS LIZATE GEL
TR201111221T2 (en) Pharmaceutical combinations of simethicone and otilonium.
EA201070544A1 (en) NEW CLASS OF THERAPEUTIC SUBSTANCES STRENGTHENING THE DIFFUSION OF LOW MOLECULAR COMPOUNDS
EA201000735A1 (en) COMPOSITIONS OF MULTIPYPE HPV PEPTIDES AND METHODS OF TREATMENT OR PREVENTION OF PAPILLOMAVIRUS INFECTION IN HUMAN
CL2008000592A1 (en) COMPOUNDS DERIVED FROM REPLACED PIRROL, SUPPRESSORS OF THE ACID SECRETION; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OR PROFILAXIS IN DISEASES SUCH AS PEPTIC ULCERA, GASTRITIS, ESOFAGITIS, AMONG OTHERS.
CL2009000402A1 (en) Substituted 2-amino-acetamide derived compounds; pharmaceutical composition; Useful in the treatment of lung diseases, rheumatic disease, autoimmune disease, among others.
MX342323B (en) Solid composition for the oral administration of dyes and diagnostic use thereof.
ECSP11010910A (en) BROMO CHLORIDE COMPOSITIONS TO REMOVE MERCURY FROM EMISSIONS PRODUCED DURING FUEL COMBUSTION
EA201171043A1 (en) COMPOSITIONS AND METHODS OF LONG-TERM THERAPY WITH THE USE OF AMINOPYRIDINES
EA201201623A1 (en) TREATMENT OF DIABETES TYPE 2
UA107204C2 (en) ANTI-FUNCTIONAL COMPOSITION CONTAINING THE PYTHIUM OLIGANDRUM Fungal Organism